Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 3/20 | 0.30 |
| ▸ | LAP3 | P28838 | 2/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17449157 | 0.88 | — | — | |
| SCHEMBL1001958 | 0.76 | MAPT (0.38) | MAPTTSHRALDH1A1 | |
| SCHEMBL19021023 | 0.75 | MAPT (0.33) | MAPTTSHR | |
| SCHEMBL13995952 | 0.74 | FDPS (0.36) | TSHRALDH1A1 | |
| Water SCHEMBL28633420 | 0.74 | MAPT (0.36) | MAPTTSHRALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29109690 | 0.74 | MAPT (0.36) | MAPTTSHRALDH1A1 | |
| SCHEMBL79152 | 0.74 | MAPT (0.36) | MAPTTSHRALDH1A1 | |
| SCHEMBL15203100 | 0.74 | ALDH1A1 (0.30) | TSHRALDH1A1 | |
| SCHEMBL13995961 | 0.74 | FDPS (0.36) | TSHRALDH1A1 | |
| SCHEMBL13995870 | 0.74 | ALDH1A1 (0.36) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158610-A1 | NONIONIC SURFACTANT COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-08 | — | — | US | disclosed |
| US-9382192-B2 | Nonionic surfactant compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160016886-A1 | NONIONIC SURFACTANT COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158610-A1 | NONIONIC SURFACTANT COMPOSITIONS | SPNS2, SGMS2, SGMS1 | MAPT 3098/4885TSHR 2600/4885ALDH1A1 4568/4885 |
| US-20160016886-A1 | NONIONIC SURFACTANT COMPOSITIONS | SPNS2, SGMS2, SGMS1 | MAPT 3415/4885TSHR 2643/4885ALDH1A1 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.